Skip to main content
. Author manuscript; available in PMC: 2015 Mar 21.
Published in final edited form as: Biochem Biophys Res Commun. 2014 Jan 23;445(4):774–779. doi: 10.1016/j.bbrc.2014.01.034

Figure 4. MiRNA regulatory map for glycogenes involved in blood group and Lewis antigens.

Figure 4

A schematic illustration of the glycogenes involved in the terminal modification processing steps leading to blood group and Lewis antigen structures on (A) Type I and (B) Type II LacNAc cores. Pathway is annotated as in Figure 1. “Highly regulated” glycogenes are denoted with an asterisk (*).